Tumor Ablation Market Booms Amid Rising Cancer Cases and Demand for Minimally Invasive Therapies - Global Outlook 2025 | Top key players - Healthtronics, BVM Medical Limited, COMSOL.

The Global Tumor Ablation Market reached US$ 797.4 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 2,079.2 million by 2031. The global tumor ablation market is expected to exhibit a CAGR of 13.1% during the forecast period (2024-2031).

The Tumor Ablation Market, as examined by DataM Intelligence, provides a thorough industry overview enriched with detailed insights, historical data, and essential statistics. The report extensively explores market dynamics and competitive landscapes, featuring profiles of leading companies, their product offerings, pricing strategies, financials, growth plans, and geographic footprint.

Unlock exclusive insights with our detailed sample report (Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/tumor-ablation-market?sz

The Tumor Ablation Market involves minimally invasive procedures that destroy cancerous tissues using methods such as radiofrequency, microwave, cryoablation, or laser techniques. These procedures are widely used in treating liver, lung, kidney, and bone tumors. Growing preference for non-surgical treatments, advancements in imaging technologies, and rising cancer prevalence globally are key factors driving market expansion.

Prominent Industry players in the Tumor Ablation Market

The prominent players in Tumor Ablation market research report are: Medtronic, PLC., AngioDynamics Inc., Boston Scientific Corporation, Healthtronics, BVM Medical Limited, COMSOL, Galil Medical, Inc., INTIO Inc., Misonix, Inc., NeuWave Medical, Inc., and SonaCare Medical among others.

The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Industry News

In March 2023, AngioDynamics announced a strategic partnership with Minimax Medical to expand the international distribution of its product portfolio. Effective from November 15, 2022, the agreement also includes the global distribution of Minimax Medical's advanced Radiofrequency Ablation System, used for treating tumors and nodules enhancing access to minimally invasive cancer therapies worldwide.

In August 2022, Bioventus Inc., a global leader in active healing innovations, received 510(k) clearance from the U.S. FDA for its neXus SonaStar Elite handpiece. This device, part of the neXus Ultrasonic Surgical Aspirator System, offers an integrated solution for both soft and hard tissue removal. Powered by a proprietary digital algorithm, the platform delivers enhanced precision, versatility, and control, and now supports multiple frequencies, including the newly approved 36 kHz SonaStar Elite handpiece.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/tumor-ablation-market

Market Segments

By Technology: Radiofrequency (rf) Ablation, Microwave Ablation, Cryoablation, Other Technologies.

By Application: Liver cancer, Lung cancer, Kidney cancer, Bone Metastasis, Others.

By Treatment Mode: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation.

The Tumor Ablation industry is undergoing swift expansion, fueled by breakthroughs in medical technology, growing demand for cutting-edge therapies, and an increasing emphasis on patient-centric care. As the sector advances, in-depth market analysis is essential to track evolving trends, regulatory developments, and new opportunities.

Regions Covered:

The global Tumor Ablation Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

FAQs:

✒ What is driving the growth of the Tumor Ablation Market?
✒ Who are the prominent players in the Tumor Ablation Market?
✒ How is the regulatory landscape affecting the Tumor Ablation Market?
✒ What regions are expected to see the highest growth?
✒ What are the key challenges faced by the Tumor Ablation Market?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Looking for Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=tumor-ablation-market?sz

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.